Analyst Research
| Report Title | Price |
|---|---|
|
Trading Report for (JNJ). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Johnson & Johnson Announces Completion of Synthes Inc Acquisition
Johnson & Johnson announced the completion of the acquisition of Synthes, Inc. for a total purchase price of $19.7 billion in cash and stock. Synthes will be integrated with the DePuy franchise to establish the DePuy Synthes Companies of Johnson & Johnson. Under the terms of the agreement, each share of Synthes common stock will be exchanged for CHF55.65 in cash and 1.7170 shares of Johnson & Johnson common stock
Latest Key Developments in Pharmaceuticals
- Share this
- Link this
- Digg this
Follow Reuters